CLINICAL_TRIALS
trial_result
· 2025-04-20
Clinical Trial Update: Treatment of Chronic Itch in Patients Under Arsenic Exposure With Naloxone [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluated naloxone for treating chronic pruritus in patients exposed to arsenic, with results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xiangya Hospital of Central South University | Conditions: Chronic Pruritus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-04-20